Flu Vaccine Testimony: Chiron's View on Preparedness


In early 2004, long before the news that Chiron Corp.'s Fluvirin would not be available for the 2004-2005 flu season, firm president Howard Pien testified before the U.S. House of Representatives about the company's role in meeting the nation's vaccine needs. Read what he had to say.

Click below to access this white paper.

Author: Howard Pien, President, Chiron Corp.

Find more white papers on Process Operations

View all white papers»